As the use of biologic therapies continues to expand across hospital specialties, the conversation around biosimilars has never been more important. With pressures on medicines budgets, the need for safe, effective and well-managed biosimilar adoption is becoming a core focus for hospital pharmacy teams across the NHS.
Against this backdrop, Hospital Pharmacy Europe is launching a Biosimilars Virtual Study Day, taking place on Wednesday, 4 March 2026. This free, CPD-accredited online event is designed to support hospital pharmacy professionals in navigating this exciting and rapidly developing area of practice.
Our full-day virtual programme brings together experienced pharmacists, pharmacy leaders and medicines optimisation specialists to explore the clinical science, operational challenges and success stories of best practice surrounding biosimilars across a range of specialisms.
Delegates will gain practical insights into switching strategies, implementation considerations and the evolving regulatory and therapeutic landscape of biosimilars in UK healthcare.
Offering the chance to gain an all-important planned CPD learning activity for your revalidation, the study day is delivered in a flexible format: join live sessions throughout the day or access the content on demand to fit in with your professional schedule.
If you’re able to join live, you will have the opportunity to hear directly from the experts and engage in live Q&A, ensuring the learning is both relevant and actionable in your own practice.
Key biosimilar highlights include
- Expert-led sessions offering practical insight for hospital pharmacy
- Practical guidance on biosimilar implementation and adoption strategies
- CPD-accredited learning with both live and on-demand access
- Interactive presentations, case studies and opportunities for Q&A
Ideal for hospital pharmacists, and those involved or interested in biologics, biosimilars and medicines optimisation, this event provides valuable knowledge that can be applied directly to your practice.
Sign up now and be amongst the first to register secure your free place and stay at the forefront of biosimilar education and implementation.
